Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis

Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naïve patients with type 2 diabetes: a systematic analysis

Basal insulin treatment for type 2 diabetes is usually initiated on a background of oral glucose-lowering medications (OGLM). We wanted to examine the influence of various OGLMs on fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) values achieved after titration. A PubMed literature search ret...

Full description

Bibliographic Details
Main Authors:	Michael A Nauck, Dominik Wollenhaupt, Jannik Wolters, Mirna Abd El Aziz
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	BMJ Open Diabetes Research & Care
Online Access:	https://drc.bmj.com/content/11/4/e003296.full

Similar Items

Basal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
by: V.I. Katerenchuk
Published: (2023-03-01)

Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients
by: Yejee Lim, et al.
Published: (2022-06-01)

Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
by: Roopa Mehta, et al.
Published: (2021-01-01)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Sami N. Nasrallah, et al.
Published: (2012-04-01)

HORMONE SIGNALING - BASAL INSULIN-SECRETION AND ACUTE INSULIN-RESPONSE IN NORMAL AND GLUCOSE INTOLERANT MAN
by: Rice, H, et al.
Published: (1993)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
by: Turner, R, et al.
Published: (1979)

Classification of Non-Insulin Glucose Lowering Drugs
by: Sanjay Kalra, et al.
Published: (2022-02-01)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
by: Holman, R, et al.
Published: (1979)

Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings.
by: Lang, D, et al.
Published: (1979)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
by: Elena V. Buryukova, et al.
Published: (2017-12-01)

Titrating insulin in patients with type 2 diabetes using a structured selfmonitoring blood glucose regimen
by: K Kalweit, et al.
Published: (2018-07-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)

Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring
by: Abe S, et al.
Published: (2011-07-01)

Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach
by: Anas El Fathi, et al.
Published: (2022-01-01)

Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man.
by: Lang, D, et al.
Published: (1981)

Effect of ficus deltoidea extracts on hepatic basal and insulin-stimulated glucose uptake
by: Adam, Z., et al.
Published: (2009)

Protocol for in vivo measurement of basal and insulin-stimulated glucose uptake in mouse tissues
by: Meng Zhao, et al.
Published: (2023-06-01)

Low fasting glucose‐to‐estimated average glucose ratio was associated with superior response to insulin degludec/aspart compared with basal insulin in patients with type 2 diabetes
by: Han Na Jang, et al.
Published: (2022-01-01)

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
by: Shinje Moon, et al.
Published: (2021-09-01)

CYCLICAL VARIATION (HUNTING) OF BASAL PLASMA GLUCOSE AND INSULIN CONCENTRATIONS IN NORMAL AND DIABETIC MAN
by: Matthews, D, et al.
Published: (1978)

Design, synthesis, and evaluation of insulin bioconjugates for the application of enhanced basal and glucose-responsive activity
by: Cortinas, Abel Bryan.
Published: (2019)

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
by: Holman, R, et al.
Published: (2007)

Insulin degludec: overview of a novel ultra long-acting basal insulin.
by: Gough, S, et al.
Published: (2013)

Insulin degludec: Overview of a novel ultra long-acting basal insulin
by: Gough, S, et al.
Published: (2013)

Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan
by: Ahsan Saleem, et al.
Published: (2016-12-01)

Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
by: Farmer, A, et al.
Published: (2011)

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
by: Saxena, R, et al.
Published: (2010)

Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation
by: Xia Zhou, et al.
Published: (2020-07-01)

Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study
by: Sang Soo Kim, et al.
Published: (2015-12-01)

Oral Insulin
by: Kalra Sanjay, et al.
Published: (2010-11-01)

Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial
by: Hu X, et al.
Published: (2021-03-01)

Basal insulin therapy in type 2 diabetes.
by: Bethel, M, et al.
Published: (2005)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
by: Kress S, et al.
Published: (2021-03-01)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
by: Wang F, et al.
Published: (2012-07-01)

Engineering glucose-responsive insulin
by: Yi Zeng, et al.
Published: (2019-09-01)

Assessing the test–retest repeatability of insulin resistance measures: Homeostasis model assessment 2 and oral glucose insulin sensitivity
by: Catherine A.P. Crofts, et al.
Published: (2017-10-01)

A practical guide to basal and prandial insulin therapy.
by: Holman, R, et al.
Published: (1985)

Pulsatile, synchronous basal insulin and glucagon secretion in man.
by: Lang, D, et al.
Published: (1982)

A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
by: Phillips, M, et al.
Published: (1979)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
by: Sumie Mitsuishi, et al.
Published: (2015-01-01)